BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.540
-0.120 (-7.23%)
At close: May 7, 2026, 4:00 PM EDT
1.620
+0.080 (5.19%)
After-hours: May 7, 2026, 7:06 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $11.61 million as of May 7, 2026. Its market cap has decreased by -23.09% in one year.
Market Cap
11.61M
Enterprise Value
-8.61M
1-Year Change
-23.09%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $11.61M, a decrease of -77.67%. That is a compound annual growth rate of -23.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 12.50M | 43.68% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hoth Therapeutics | 13.58M |
| Cellectar Biosciences | 13.48M |
| Cyclerion Therapeutics | 13.31M |
| Moleculin Biotech | 13.29M |
| Intensity Therapeutics | 13.23M |
| Phio Pharmaceuticals | 13.13M |
| Jupiter Neurosciences | 13.08M |
| BioCardia | 12.03M |